Abbott has positive data for Esprit drug-eluting resorbable scaffold
Abbott (NYSE:ABT) today announced data supporting its Esprit BTK everolimus-eluting resorbable scaffold system.
United States San Francisco Brian Derubertis Jennifer Jones Mcmeans Weill Cornell Medical Center Transcatheter Cardiovascular Therapeutics
Source: massdevice.com